TARIFFS LATEST US, China to slash tariffs for 90 days OTC Markets EXMKT • USD Novo Integrated Sciences, Inc. (NVOS) Follow Add holdings 0.0010 -0.0002 (-16.67%) At close: May 9 at 4:00:00 PM EDT All News Press Releases SEC Filings Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results BELLEVUE, Wash., December 18, 2024--Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results BELLEVUE, Wash., July 19, 2024--Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program BELLEVUE, Wash., July 18, 2024--Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program BELLEVUE, Wash., June 13, 2024--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the "Company" or "Novo") announced today that it has received confirmation of the issuance of a Standby Letter of Credit ("SBLC") by HSBC for delivery by Swift MT760, as part of a program designed for monetizing SBLCs. As previously reported, the Company entered into an application for the monetizing program whereby the Company is projected to receive gross funding proceeds of approximately $78 million under the SBLC Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million BELLEVUE, Wash., June 06, 2024--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the "Company" or "Novo"), today announced the Company’s Board of Directors has approved an increase of up to $10 million maximum amount, from the previously announced up to $5 million maximum amount, for the repurchase of the Company's outstanding common stock from time to time in the open market at prevailing market prices or in privately negotiated transactions. The increased maximum amount available for purchase un Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products BELLEVUE, Wash., June 05, 2024--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the "Company" or "Novo") announced today that its wholly owned Canadian subsidiary, Acenzia Inc. ("Acenzia"), has been selected by Protein Industries Canada to participate in a new project to bring new protein products with a superior nutritional amino acid profile to the global marketplace. The total project is expected to see approximately $5.4 million invested into the development, reformulation, and commercializat Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note BELLEVUE, Wash., June 03, 2024--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the "Company" or "Novo") announced today the Company and RC Consulting Consortium Group LLC, in favor of SCP Tourbillion Monaco ("RC"), have amended the prepayment terms and conditions of the previously disclosed $70,000,000 promissory note, dated April 26, 2023 (the "RC Note") to provide that, at any time after 12 months and no later than 60 months from the commencement of the term of the RC Note and prior to an even Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program BELLEVUE, Wash., May 31, 2024--Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program BELLEVUE, Wash., May 30, 2024--Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program Performance Overview Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return NVOS S&P 500 (^GSPC) YTD -98.08% -3.77% 1-Year -99.83% +8.55% 3-Year -100.00% +41.81%